Skip to content
Sign up today for access to the latest pediatric solutions!
Sign up today for access to the latest pediatric solutions!

IP License - Antepartum Administration of Lactoferrin for Potential Preventative Intervention Against Neonatal Sepsis

IP Licensing
Availability: Available On Demand

For informational purposes only. Please contact seller directly for more details.

Share This:

Prenatal maternal vaginal administration of lactoferrin (LF) significantly decreases vaginal bacterial loads of a clinically significant neonatal invasive E. coli isolate. Placental bacterial loads, and burden of infection in the offspring were also significantly decreased. Prenatal lactoferrin is a potential preventative intervention against neonatal sepsis. Patent Pending

Shipping Information

Free shipping on orders in the continental United States.
We are unable to ship outside of the United States at this time.

Returns

Please contact the seller directly for their return policy and to handle returns. Customer will be responsible for return shipping fees.